Rodin Therapeutics rodintherapeutics.com


Public list: Pharma Startups (6570) Google In Healthcare (60) Neuroscience Startups (947)

Rodin Therapeutics discovers and develops therapeutics by applying chemical strategies to target protein complexes that selectively modulate gene expression. On November 18, 2019, Rodin Therapeutics was acquired by Alkermes at a valuation of $100M.

Rodin Therapeutics discovers and develops therapeutics by applying chemical strategies to target protein complexes that selectively modulate gene expression. On November 18, 2019, Rodin Therapeutics was acquired by Alkermes at a valuation of $100M.

Company (Acquired)

Phone:

Fax:

101 Huntington Avenue
21st Floor, Suite 2150
Boston, 02199
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Rodin Therapeutics $41M Nov 18, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Rodin Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Inhibitors of histone deacetylase Jun 25, 2015 May 29, 2018 Patent
Bicyclic inhibitors of histone deacetylase Jan 11, 2018 Apr 24, 2018 Patent
Reconfigurable snowboard/ downhill skis and binding Apr 28, 2014 Sep 15, 2015 Patent
Reconfigurable snowboard/downhill skis Jan 25, 2013 Apr 29, 2014 Patent